Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Efficacy of YH4808 in Reflux Esophagitis
NCT01538849Phase 2Completed
- Sponsor
- Yuhan
- Start
- Dec 2012
- Primary completion
- Nov 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of YH4808 in reflux esophagitis, sponsored by Yuhan. Started Dec 2012; status: completed.
02
Drugs
YH4808
03
Conditions
reflux esophagitis
Beyond the preview
Go deeper on NCT01538849.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01538849.